U.S. FDA backs Pfizer COVID-19 booster shot for 12- to 15-year-olds

Pubblicato su Lunedì, 03 Gennaio 2022 16:52 Scritto da CBC | World News

The U.S. Food and Drug Administration has authorized the use of a third dose of the Pfizer-BioNTech COVID-19 vaccine for children aged between 12 and 15 years, and narrowed the time for all booster shots by a month to five months after the primary doses.
Read more: U.S. FDA backs Pfizer COVID-19 booster shot for 12- to 15-year-olds

Letto 35 volte